Strategy Capital LLC cut its stake in Tesla, Inc. (NASDAQ:TSLA - Free Report) by 34.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 104,855 shares of the electric vehicle producer's stock after selling 54,625 shares during the period. Tesla accounts for approximately 3.1% of Strategy Capital LLC's portfolio, making th...
Strategy Capital LLC cut its stake in Tesla, Inc. (NASDAQ:TSLA - Free Report) by 34.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 104,855 shares of the electric vehicle producer's stock after selling 54,625 shares during the period. Tesla accounts for approximately 3.1% of Strategy Capital LLC's portfolio, making the stock its 10th largest position. Strategy Capital LLC's holdings in Tesla were worth $46,631,000 at the end of the most recent reporting period. Get Tesla alerts: Sign Up Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Narwhal Capital Management grew its stake in shares of Tesla by 32.8% in the 3rd quarter. Narwhal Capital Management now owns 9,516 shares of the electric vehicle producer's stock worth $4,232,000 after buying an additional 2,350 shares during the last quarter. Gamco Investors INC. ET AL boosted its holdings in Tesla by 29.6% in the third quarter. Gamco Investors INC. ET AL now owns 32,576 shares of the electric vehicle producer's stock worth $14,487,000 after acquiring an additional 7,446 shares in the last quarter. Norges Bank purchased a new stake in shares of Tesla in the second quarter worth $11,839,824,000. Police & Firemen s Retirement System of New Jersey increased its holdings in shares of Tesla by 5.6% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 427,150 shares of the electric vehicle producer's stock valued at $135,688,000 after acquiring an additional 22,607 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its position in shares of Tesla by 8.8% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 48,504 shares of the electric vehicle producer's stock worth $21,571,000 after purchasing an additional 3,935 shares during the last quarter. Hedge funds and other institutional investor...
Swiss National Bank reduced its position in shares of Tesla, Inc. (NASDAQ:TSLA - Free Report) by 4.6% in the third quarter, according to its most recent filing with the SEC. The fund owned 8,356,175 shares of the electric vehicle producer's stock after selling 406,900 shares during the quarter. Tesla comprises approximately 2.2% of Swiss National Bank's holdings, making the stock its 8th largest h...
Swiss National Bank reduced its position in shares of Tesla, Inc. (NASDAQ:TSLA - Free Report) by 4.6% in the third quarter, according to its most recent filing with the SEC. The fund owned 8,356,175 shares of the electric vehicle producer's stock after selling 406,900 shares during the quarter. Tesla comprises approximately 2.2% of Swiss National Bank's holdings, making the stock its 8th largest holding. Swiss National Bank owned 0.25% of Tesla worth $3,716,158,000 at the end of the most recent quarter. Get Tesla alerts: Sign Up Other large investors also recently bought and sold shares of the company. Pinpoint Asset Management Singapore Pte. Ltd. grew its position in Tesla by 1,560.0% in the third quarter. Pinpoint Asset Management Singapore Pte. Ltd. now owns 166 shares of the electric vehicle producer's stock worth $74,000 after acquiring an additional 156 shares in the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of Tesla by 12.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,770,212 shares of the electric vehicle producer's stock worth $786,800,000 after purchasing an additional 195,530 shares during the period. Schroder Investment Management Group increased its position in shares of Tesla by 3.7% during the 3rd quarter. Schroder Investment Management Group now owns 1,642,893 shares of the electric vehicle producer's stock valued at $730,627,000 after purchasing an additional 58,732 shares during the last quarter. Fort Sheridan Advisors LLC lifted its position in Tesla by 2.2% in the third quarter. Fort Sheridan Advisors LLC now owns 2,131 shares of the electric vehicle producer's stock worth $948,000 after buying an additional 45 shares during the last quarter. Finally, PFG Advisors boosted its stake in Tesla by 16.9% during the third quarter. PFG Advisors now owns 17,868 shares of the electric vehicle producer's stock worth $7,946,000 after buying an additional 2,588 shares during the period. Institutional invest...
Schroder Investment Management Group raised its stake in shares of Tesla, Inc. (NASDAQ:TSLA - Free Report) by 3.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,642,893 shares of the electric vehicle producer's stock after buying an additional 58,732 shares during the quarter. Schroder Investment Management G...
Schroder Investment Management Group raised its stake in shares of Tesla, Inc. (NASDAQ:TSLA - Free Report) by 3.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,642,893 shares of the electric vehicle producer's stock after buying an additional 58,732 shares during the quarter. Schroder Investment Management Group's holdings in Tesla were worth $730,627,000 at the end of the most recent reporting period. Get Tesla alerts: Sign Up A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Chapman Financial Group LLC bought a new position in Tesla in the 2nd quarter valued at $26,000. Manning & Napier Advisors LLC purchased a new stake in shares of Tesla in the third quarter worth $29,000. CoreFirst Bank & Trust bought a new stake in Tesla during the second quarter valued at $30,000. ESL Trust Services LLC increased its stake in Tesla by 1,900.0% in the 2nd quarter. ESL Trust Services LLC now owns 100 shares of the electric vehicle producer's stock worth $32,000 after acquiring an additional 95 shares during the last quarter. Finally, Delos Wealth Advisors LLC purchased a new stake in shares of Tesla in the 2nd quarter valued at about $32,000. 66.20% of the stock is owned by hedge funds and other institutional investors. Wall Street Analysts Forecast Growth TSLA has been the topic of several research analyst reports. HSBC restated a "reduce" rating on shares of Tesla in a research report on Monday, November 17th. Glj Research reissued a "sell" rating on shares of Tesla in a report on Tuesday, February 24th. Tigress Financial began coverage on shares of Tesla in a report on Thursday, February 12th. They set a "buy" rating and a $550.00 price objective for the company. Barclays reiterated a "neutral" rating on shares of Tesla in a research report on Wednesday, March 4th. Finally, Truist Financial lowered their price target on...
Swiss National Bank lowered its holdings in shares of Alphabet Inc. (NASDAQ:GOOG - Free Report) by 5.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,162,400 shares of the information services provider's stock after selling 813,700 shares during the period. Alphabet accounts for 2.0% of Swiss National B...
Swiss National Bank lowered its holdings in shares of Alphabet Inc. (NASDAQ:GOOG - Free Report) by 5.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,162,400 shares of the information services provider's stock after selling 813,700 shares during the period. Alphabet accounts for 2.0% of Swiss National Bank's investment portfolio, making the stock its 9th largest holding. Swiss National Bank owned 0.12% of Alphabet worth $3,449,253,000 as of its most recent SEC filing. Get Alphabet alerts: Sign Up Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Brighton Jones LLC raised its stake in shares of Alphabet by 5.6% during the fourth quarter. Brighton Jones LLC now owns 120,253 shares of the information services provider's stock worth $22,901,000 after purchasing an additional 6,410 shares during the last quarter. Ignite Planners LLC grew its position in Alphabet by 1.0% in the 2nd quarter. Ignite Planners LLC now owns 14,506 shares of the information services provider's stock valued at $2,697,000 after buying an additional 144 shares during the last quarter. Sequoia Financial Advisors LLC increased its stake in Alphabet by 7.4% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 594,959 shares of the information services provider's stock valued at $105,540,000 after buying an additional 41,132 shares during the period. Reston Wealth Management LLC increased its stake in Alphabet by 2.6% in the 2nd quarter. Reston Wealth Management LLC now owns 6,407 shares of the information services provider's stock valued at $1,137,000 after buying an additional 164 shares during the period. Finally, RPS Advisory Solutions LLC raised its position in Alphabet by 23.9% during the 2nd quarter. RPS Advisory Solutions LLC now owns 6,575 shares of the information services provider's stock worth $1,166,000 after buying an addit...
Schroder Investment Management Group grew its position in shares of Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM - Free Report) by 1.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,214,475 shares of the semiconductor company's stock after purchasing an additional 131,301 sha...
Schroder Investment Management Group grew its position in shares of Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM - Free Report) by 1.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,214,475 shares of the semiconductor company's stock after purchasing an additional 131,301 shares during the quarter. Taiwan Semiconductor Manufacturing makes up about 1.5% of Schroder Investment Management Group's portfolio, making the stock its 11th biggest holding. Schroder Investment Management Group owned 0.14% of Taiwan Semiconductor Manufacturing worth $1,971,211,000 at the end of the most recent reporting period. Get TSM alerts: Sign Up A number of other institutional investors and hedge funds also recently added to or reduced their stakes in TSM. Heartwood Wealth Advisors LLC acquired a new stake in shares of Taiwan Semiconductor Manufacturing during the 3rd quarter worth approximately $32,000. Resources Management Corp CT ADV acquired a new position in Taiwan Semiconductor Manufacturing in the second quarter valued at about $32,000. Cedar Wealth Management LLC boosted its stake in Taiwan Semiconductor Manufacturing by 91.4% during the third quarter. Cedar Wealth Management LLC now owns 134 shares of the semiconductor company's stock worth $37,000 after buying an additional 64 shares during the period. Fairman Group LLC lifted its holdings in shares of Taiwan Semiconductor Manufacturing by 171.2% in the 3rd quarter. Fairman Group LLC now owns 141 shares of the semiconductor company's stock worth $39,000 after acquiring an additional 89 shares during the last quarter. Finally, Riggs Asset Managment Co. Inc. purchased a new position in shares of Taiwan Semiconductor Manufacturing during the 2nd quarter worth approximately $41,000. Hedge funds and other institutional investors own 16.51% of the company's stock. Wall Street Analysts Forecast Growth Several rese...
Schroder Investment Management Group lifted its holdings in Oracle Corporation (NYSE:ORCL - Free Report) by 15.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,337,892 shares of the enterprise software provider's stock after purchasing an additional 318,705 shares during the quarter. Schroder Investment Manageme...
Schroder Investment Management Group lifted its holdings in Oracle Corporation (NYSE:ORCL - Free Report) by 15.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,337,892 shares of the enterprise software provider's stock after purchasing an additional 318,705 shares during the quarter. Schroder Investment Management Group owned 0.08% of Oracle worth $657,509,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Get Oracle alerts: Sign Up Several other institutional investors also recently modified their holdings of ORCL. Darwin Wealth Management LLC boosted its holdings in shares of Oracle by 130.0% during the 3rd quarter. Darwin Wealth Management LLC now owns 115 shares of the enterprise software provider's stock valued at $32,000 after acquiring an additional 65 shares during the last quarter. Winnow Wealth LLC bought a new position in Oracle during the second quarter valued at approximately $28,000. Financial Consulate Inc. bought a new stake in Oracle in the 3rd quarter worth approximately $37,000. Corundum Trust Company INC purchased a new stake in Oracle during the 3rd quarter valued at $39,000. Finally, Collier Financial bought a new position in shares of Oracle during the 3rd quarter valued at $38,000. 42.44% of the stock is owned by hedge funds and other institutional investors. Oracle Trading Down 1.2% Shares of NYSE:ORCL opened at $152.95 on Monday. The stock has a 50 day moving average of $169.72 and a 200 day moving average of $220.62. The company has a market cap of $439.45 billion, a PE ratio of 28.75, a price-to-earnings-growth ratio of 1.34 and a beta of 1.66. Oracle Corporation has a 12-month low of $118.86 and a 12-month high of $345.72. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 3.28. Oracle (NYSE:ORCL - Get Free Report) last released its earnings results on Wednesday, December 10th. ...
Airline stocks were set to continue their recent sharp selloff amid fears that travel demand will drop as the escalating Middle East conflict sends crude oil prices above $100 a barrel.
Airline stocks were set to continue their recent sharp selloff amid fears that travel demand will drop as the escalating Middle East conflict sends crude oil prices above $100 a barrel.
ClearPoint Neuro, Inc. CLPT shares soared 8.1% in the last trading session to close at $10. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 26.4% loss over the past four weeks. ClearPoint Neuro scored a strong price increase on investors’ optimism surrounding the company’s impending fourth quarter 2025 financial results...
ClearPoint Neuro, Inc. CLPT shares soared 8.1% in the last trading session to close at $10. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 26.4% loss over the past four weeks. ClearPoint Neuro scored a strong price increase on investors’ optimism surrounding the company’s impending fourth quarter 2025 financial results, which is slated to release on March 17, 2026. Per the Zacks Consensus Estimate, the company’s revenues are expected to increase 24.8% year over year. Loss per share is pegged at 22 cents for the fourth quarter. This company is expected to post quarterly loss of $0.22 per share in its upcoming report, which represents a year-over-year change of -10%. Revenues are expected to be $9.7 million, up 24.8% from the year-ago quarter. Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. For ClearPoint Neuro, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on CLPT going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> ClearPoint Neuro is part of the Zacks Medical - Instruments industry. EDAP TMS S.A. EDAP, another stock in the same industry, closed the last trading session 2.8% lower at $4.13. EDAP has returned 6.3% in the past month. EDAP TMS' consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.16. Compared to the company's year-ago EPS, this represents a change of -220%. EDAP TMS currently boasts a Zacks Ra...
Factorial, a Spanish startup supplying human resources software to enterprises, is in early discussions to raise new funding that will double its valuation to $2 billion, according to people familiar with the matter. The startup may raise as much as $200 million, one of the people said, requesting anonymity as the information is not public. The size of the round and valuation are not yet finalized...
Factorial, a Spanish startup supplying human resources software to enterprises, is in early discussions to raise new funding that will double its valuation to $2 billion, according to people familiar with the matter. The startup may raise as much as $200 million, one of the people said, requesting anonymity as the information is not public. The size of the round and valuation are not yet finalized, the people said. Factorial declined to comment. The valuation would turn Factorial into one of Spain’s most valuable startups. Formed in 2016, the company offers software that can manage functions such as employee time off, payroll, training and recruitment. It was last valued at $1 billion in 2022. The company said it reached $100 million in annual recurring revenue, a metric used by software startups to demonstrate customer growth, last September. HR software is a fiercely competitive field for startups. The market was turbocharged during the Covid-19 pandemic, when many companies had to manage a remote workforce and found existing tools fell short. The rise of artificial intelligence tools that can take on rote administrative work has also impacted the sector. Two of the biggest startups in the space, Deel and Rippling, are embroiled in a bitter legal battle with Rippling accusing Deel of corporate espionage and Deel filed its own suit against Rippling, alleging defamation. German HR software startup Personio last raised $200 million at a valuation of $8.5 billion in June 2022.
Aureus Greenway Holdings ( AGH ) has signed a definitive merger agreement with Powerus, a U.S. Army Special Operations veteran-founded firm developing autonomous drone systems for high-risk military and commercial environments. Notable investors in the combined company include American Venture Partners, Eric Trump, and Donald Trump Jr., with additional support from U.S. drone manufacturer Unusual ...
Aureus Greenway Holdings ( AGH ) has signed a definitive merger agreement with Powerus, a U.S. Army Special Operations veteran-founded firm developing autonomous drone systems for high-risk military and commercial environments. Notable investors in the combined company include American Venture Partners, Eric Trump, and Donald Trump Jr., with additional support from U.S. drone manufacturer Unusual Machines ( UMAC ) and a strategic $50 million investment . UMAC shares rose 10% in premarket trading, and AGH was up 5%. “The need for and uses of autonomous technologies, such as those produced by Powerus, are front page news given developments in the Middle East and elsewhere," Matthew J. Saker , interim CEO of AGH, stated. "This business combination is not just a compelling opportunity for AGH stockholders, but one made even more relevant by current geopolitical uncertainties." Under the terms of the agreement, Powerus will merge with and into a newly-formed subsidiary of AGH, with Powerus continuing as the surviving entity and AGH adopting the name “Powerus Corporation.” The combined company expects to be listed on Nasdaq under the ticker “PUSA.” The merger transaction was unanimously approved by the boards of directors of both companies and a majority of each company’s stockholders. More on Aureus Greenway Holdings Inc., Dominari Holdings, etc. Unusual Machines: A Speculative Bet Supported By Solid Fundamentals Unusual Machines: The Growth Story Is Strong (Rating Upgrade) U.S. drone market faces shake-up after FCC ruling, Needham says Seeking Alpha’s Quant Rating on Aureus Greenway Holdings Inc. Financial information for Aureus Greenway Holdings Inc.
The presenter also thanked the doctors and nurses who have been helping his dad, and to those who have sent him messages of support, saying: "In times like these it's so nice to feel the love from people."
The presenter also thanked the doctors and nurses who have been helping his dad, and to those who have sent him messages of support, saying: "In times like these it's so nice to feel the love from people."
Byrna Technologies ( BYRN ) expects Q1 FY2026 revenue of approximately $29.0M ($30.72M consensus), an 11% increase from $26.2 million in Q1 FY2025. First quarter revenue reflects the typical post-holiday seasonal moderation following Byrna’s strong holiday-driven fourth quarter. The quarter ended with approximately $1.1 million in backlog, slightly above typical first-quarter levels due to shipmen...
Byrna Technologies ( BYRN ) expects Q1 FY2026 revenue of approximately $29.0M ($30.72M consensus), an 11% increase from $26.2 million in Q1 FY2025. First quarter revenue reflects the typical post-holiday seasonal moderation following Byrna’s strong holiday-driven fourth quarter. The quarter ended with approximately $1.1 million in backlog, slightly above typical first-quarter levels due to shipment timing at quarter-end. During the quarter, Byrna continued to generate sales across its multiple distribution channels, including its direct-to-consumer platform and expanding retail footprint, as the Company continues to broaden its omnichannel distribution strategy. Byrna plans to report its full financial results for the fiscal first quarter in April. BYRN -7.5% premarket to $11.08 Source: Press Release More on Byrna Technologies Byrna Technologies Inc. (BYRN) Q4 2025 Earnings Call Transcript Byrna Technologies: A 25% Pullback Creates A Fresh High-Risk, High-Reward Entry Byrna technologies appoints Conn Davis as CEO Byrna anticipates continued margin expansion and 2,000-store footprint growth in 2026 as new products launch Seeking Alpha’s Quant Rating on Byrna Technologies
MP Materials (NYSE: MP) sits at the center of one of the most consequential supply chain shifts in modern American industrial policy. With shares at $58.23, up 138.65% over the past year, the market is pricing in a geopolitical shift that has drawn significant attention: the U.S. has almost no domestic rare earth supply chain, ... The Defense Stock You’ve Never Heard Of: Why MP Materials Is a Buy
MP Materials (NYSE: MP) sits at the center of one of the most consequential supply chain shifts in modern American industrial policy. With shares at $58.23, up 138.65% over the past year, the market is pricing in a geopolitical shift that has drawn significant attention: the U.S. has almost no domestic rare earth supply chain, ... The Defense Stock You’ve Never Heard Of: Why MP Materials Is a Buy
Billionaire Aliko Dangote ’s oil refinery said it will prioritize supplying fuel in Nigeria, its home market, as long as it can access local crude. The facility, which can process 650,000 barrels a day of oil, paused local supply pending an announcement of new prices for wholesalers, Chief Executive Officer David Bird said at a briefing in Lagos on Monday. Nigeria is among the few countries on the...
Billionaire Aliko Dangote ’s oil refinery said it will prioritize supplying fuel in Nigeria, its home market, as long as it can access local crude. The facility, which can process 650,000 barrels a day of oil, paused local supply pending an announcement of new prices for wholesalers, Chief Executive Officer David Bird said at a briefing in Lagos on Monday. Nigeria is among the few countries on the continent that have refineries. Even though many nations produce several millions of barrels of crude oil a day, they lack processing capacity and must import most of their petroleum products from the Middle East. Iran War Leaves Kenya Tracking Tankers for Mideast Supply Economic Shock Looms as Trump’s Gulf War Escalates: Next Africa Oil at $85 Makes Nigeria a Winner, While Congo Has Most to Lose The US and Israel war on Iran has upended the oil market. Crude surged past $100 a barrel on Monday as more major Middle East producers cut output, including OPEC leader Saudi Arabia, with a standstill of tanker traffic through the vital Strait of Hormuz choking off supplies to the rest of the world. Dangote’s refinery is running at full capacity, Bird said. The Next Africa newsletter runs every weekday. Sign up here for the newsletter, and subscribe to the Next Africa podcast on Apple , Spotify or anywhere you listen .
Andres Barrionuevo Lopez/iStock via Getty Images Investment Overview This is my first time providing coverage of Omada Health ( OMDA ) for Seeking Alpha—the San Francisco, California-headquartered health tech firm completed its Initial Public Offering in May last year (2025), raising ~$150m at ~$19 per share. The company discusses its business as follows in its 2025 annual report/ 10K filing , sha...
Andres Barrionuevo Lopez/iStock via Getty Images Investment Overview This is my first time providing coverage of Omada Health ( OMDA ) for Seeking Alpha—the San Francisco, California-headquartered health tech firm completed its Initial Public Offering in May last year (2025), raising ~$150m at ~$19 per share. The company discusses its business as follows in its 2025 annual report/ 10K filing , shared by the company last week, alongside its Q4 and full-year 2025 financial results and business updates: We deliver virtual care between doctor’s visits, providing an engaging, personalized, and integrated experience for the individuals in our programs, which we call our “members.” Our care is designed to improve their health while delivering value for the employers, health insurance companies (“health plans”), health systems, pharmacy benefit managers (“PBMs”), and other entities that cover the cost of our programs. As of December 31, 2025, we had more than 2,000 customers, over 886,000 total members enrolled in one or more programs, and had supported nearly two million members since launch. We sell our programs to customers that cover the cost for covered individuals, either by contracting with us directly or by arranging access through entities that we call “channel partners,” which resell our programs to their own end customers. An overview of the programs Omada offers, and services it provides is shown in the slide below, taken from a company corporate presentation : Omada Health services overview (presentation) Since late October 2025, when stock traded at ~$27 per share, it has generally been in decline, reaching a low of ~$11 last month; however, in the last few weeks, it has found some upside momentum, presently priced at $14 per share, conferring a market cap valuation of ~$813m. Let's begin our analysis of the company by considering Q4 and full-year 2025 results. Omada: 2025 Earnings Analysis The company provides a fairly comprehensive overview of its Q4 and ful...
Swiss National Bank trimmed its position in shares of Qualcomm Incorporated (NASDAQ:QCOM - Free Report) by 6.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,118,100 shares of the wireless technology company's stock after selling 229,800 shares during the period. Swiss National Bank owned about 0.29% of...
Swiss National Bank trimmed its position in shares of Qualcomm Incorporated (NASDAQ:QCOM - Free Report) by 6.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,118,100 shares of the wireless technology company's stock after selling 229,800 shares during the period. Swiss National Bank owned about 0.29% of Qualcomm worth $518,727,000 as of its most recent SEC filing. A number of other institutional investors also recently modified their holdings of QCOM. Russell Investments Group Ltd. grew its position in shares of Qualcomm by 0.3% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,704,771 shares of the wireless technology company's stock worth $283,245,000 after buying an additional 4,662 shares during the last quarter. Schroder Investment Management Group raised its holdings in shares of Qualcomm by 5.0% during the third quarter. Schroder Investment Management Group now owns 1,649,755 shares of the wireless technology company's stock valued at $272,705,000 after acquiring an additional 78,129 shares in the last quarter. SNS Financial Group LLC raised its holdings in shares of Qualcomm by 1.6% during the third quarter. SNS Financial Group LLC now owns 7,462 shares of the wireless technology company's stock valued at $1,241,000 after acquiring an additional 117 shares in the last quarter. Certified Advisory Corp lifted its stake in Qualcomm by 0.6% in the third quarter. Certified Advisory Corp now owns 10,085 shares of the wireless technology company's stock worth $1,678,000 after acquiring an additional 62 shares during the period. Finally, PFG Advisors boosted its holdings in Qualcomm by 10.6% in the third quarter. PFG Advisors now owns 6,405 shares of the wireless technology company's stock valued at $1,066,000 after acquiring an additional 616 shares in the last quarter. 74.35% of the stock is currently owned by hedge funds and other institutional investors. G...
Swiss National Bank reduced its stake in Advanced Micro Devices, Inc. (NASDAQ:AMD - Free Report) by 5.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,673,875 shares of the semiconductor manufacturer's stock after selling 244,100 shares during the period. Advanced Micro Devices makes up approximately 0.4% of...
Swiss National Bank reduced its stake in Advanced Micro Devices, Inc. (NASDAQ:AMD - Free Report) by 5.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,673,875 shares of the semiconductor manufacturer's stock after selling 244,100 shares during the period. Advanced Micro Devices makes up approximately 0.4% of Swiss National Bank's investment portfolio, making the stock its 28th biggest position. Swiss National Bank owned about 0.29% of Advanced Micro Devices worth $756,186,000 as of its most recent SEC filing. Get Advanced Micro Devices alerts: Sign Up Other hedge funds have also recently added to or reduced their stakes in the company. ORG Wealth Partners LLC raised its holdings in Advanced Micro Devices by 39.7% in the 3rd quarter. ORG Wealth Partners LLC now owns 162 shares of the semiconductor manufacturer's stock valued at $26,000 after acquiring an additional 46 shares in the last quarter. Koesten Hirschmann & Crabtree INC. grew its holdings in shares of Advanced Micro Devices by 61.0% during the 3rd quarter. Koesten Hirschmann & Crabtree INC. now owns 161 shares of the semiconductor manufacturer's stock worth $26,000 after purchasing an additional 61 shares in the last quarter. Pinney & Scofield Inc. increased its position in shares of Advanced Micro Devices by 81.0% in the second quarter. Pinney & Scofield Inc. now owns 190 shares of the semiconductor manufacturer's stock worth $27,000 after purchasing an additional 85 shares during the period. Aviso Financial Inc. increased its position in shares of Advanced Micro Devices by 400.0% in the third quarter. Aviso Financial Inc. now owns 200 shares of the semiconductor manufacturer's stock worth $32,000 after purchasing an additional 160 shares during the period. Finally, Evolution Wealth Management Inc. acquired a new position in Advanced Micro Devices in the second quarter valued at about $34,000. Institutional investors ...
Swiss National Bank lowered its position in shares of Micron Technology, Inc. (NASDAQ:MU - Free Report) by 4.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,225,900 shares of the semiconductor manufacturer's stock after selling 157,200 shares during the quarter. Swiss National Bank owned approximately 0.29% of Micron Technolog...
Swiss National Bank lowered its position in shares of Micron Technology, Inc. (NASDAQ:MU - Free Report) by 4.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,225,900 shares of the semiconductor manufacturer's stock after selling 157,200 shares during the quarter. Swiss National Bank owned approximately 0.29% of Micron Technology worth $539,758,000 as of its most recent filing with the SEC. Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. REAP Financial Group LLC purchased a new position in shares of Micron Technology during the 3rd quarter worth $25,000. Barnes Dennig Private Wealth Management LLC purchased a new stake in shares of Micron Technology in the third quarter valued at $27,000. Howard Hughes Medical Institute acquired a new position in Micron Technology in the second quarter valued at $30,000. Cullen Frost Bankers Inc. increased its stake in Micron Technology by 79.3% in the third quarter. Cullen Frost Bankers Inc. now owns 199 shares of the semiconductor manufacturer's stock valued at $33,000 after purchasing an additional 88 shares during the last quarter. Finally, WealthCollab LLC lifted its position in Micron Technology by 4,500.0% during the second quarter. WealthCollab LLC now owns 276 shares of the semiconductor manufacturer's stock worth $34,000 after buying an additional 270 shares during the period. 80.84% of the stock is owned by hedge funds and other institutional investors. Get Micron Technology alerts: Sign Up Micron Technology Stock Performance Shares of MU stock opened at $370.30 on Monday. The company has a current ratio of 2.46, a quick ratio of 1.78 and a debt-to-equity ratio of 0.19. The company has a market cap of $416.78 billion, a PE ratio of 35.20 and a beta of 1.50. The company's fifty day simple moving average is $379.98 and its 200-day simple moving average is $263.57. Micron Technology, Inc...
Editas Medicine (EDIT) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.78. This compares to loss of $1 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 21.79%. A quarter ago, it was expected that this genome editing company would post a loss of $0.86 per share whe...
Editas Medicine (EDIT) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.78. This compares to loss of $1 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 21.79%. A quarter ago, it was expected that this genome editing company would post a loss of $0.86 per share when it actually produced a loss of $0.57, delivering a surprise of 33.72%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Editas , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $12.47 million for the quarter ended December 2021, surpassing the Zacks Consensus Estimate by 181.15%. This compares to year-ago revenues of $11.42 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Editas shares have lost about 45.7% since the beginning of the year versus the S&P 500's decline of -11.3%. What's Next for Editas? While Editas has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions....
Contemporary Amperex Technology Co. Ltd. shares jumped the most in about six months on Tuesday after the world’s largest maker of electric-vehicle batteries’ earnings beat analyst estimates. The stock rose as much as 9.3% in early trading Tuesday, the biggest gain on an intraday basis since Sept. 15, 2025. Net income climbed 42% in 2025 from a year earlier to 72.2 billion yuan ($10.4 billion), ahe...
Contemporary Amperex Technology Co. Ltd. shares jumped the most in about six months on Tuesday after the world’s largest maker of electric-vehicle batteries’ earnings beat analyst estimates. The stock rose as much as 9.3% in early trading Tuesday, the biggest gain on an intraday basis since Sept. 15, 2025. Net income climbed 42% in 2025 from a year earlier to 72.2 billion yuan ($10.4 billion), ahead of estimates, the Chinese company said late Monday. Revenue rose 17% as more overseas shipments and a burgeoning energy-storage business helped offset cooling demand from China’s EV market. The results solidify CATL’s position as an anchor of the global green energy transition at a time of growing uncertainty for battery makers. The sharper-than-expected slowdown in EV demand is driving some of the industry’s biggest names toward energy storage systems — a sector that’s booming due to the growing integration of renewable energy into power grids and surging demand from AI data centers. That also highlights the diverging trajectories of CATL and BYD Co. , the world’s biggest EV maker that also produces batteries. The latter’s reliance on the EV market has hammered its bottom line and it’s expected to report its worst quarterly sales decline in five years later this month as intense domestic competition and sluggish car sales in China hurt demand. Read More: CATL’s Results May Widen $120 Billion Market Cap Lead Over BYD The revenue of CATL’s energy storage segment jumped by about 9% from the prior year, while total revenues from the company’s overseas segment rose about 18%. International expansion remains a core pillar of CATL’s growth ambitions, despite the headwinds it faces from geopolitics. The company is doubling down on its licensing model to bypass trade barriers in the US and Europe, attempting to monetize its research and development without the political risk that comes with owning physical assets. In Europe, the ramp up of its multibillion-euro plant in Hungary ...
(RTTNews) - Standex International Corporation (SXI) said on Monday that it has sold its display merchandising business, Federal Industries, to AeriTek Global Holdings LLC, a portfolio company of Mill Point Capital, for around $70 million. This divestiture will support continued simplification of the portfolio and focus on larger businesses and fast-growth end-market opportunities, the company note...
(RTTNews) - Standex International Corporation (SXI) said on Monday that it has sold its display merchandising business, Federal Industries, to AeriTek Global Holdings LLC, a portfolio company of Mill Point Capital, for around $70 million. This divestiture will support continued simplification of the portfolio and focus on larger businesses and fast-growth end-market opportunities, the company noted. Standex intends to use the proceeds from the sale for organic growth opportunities, inorganic initiatives, and debt repayment. For 2025, Federal Industries reported revenue of approximately $35.7 million. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Universal Health Services ( UHS ) has entered into a definitive agreement to acquire Talkspace ( TALK ) for $5.25 per share. The enterprise value for the transaction is around $835M, which UHS intends to finance with borrowings pursuant to its existing revolving credit facility. The transaction was unanimously approved by the respective boards of directors and is expected to close during the third...
Universal Health Services ( UHS ) has entered into a definitive agreement to acquire Talkspace ( TALK ) for $5.25 per share. The enterprise value for the transaction is around $835M, which UHS intends to finance with borrowings pursuant to its existing revolving credit facility. The transaction was unanimously approved by the respective boards of directors and is expected to close during the third quarter of 2026. Talkspace ( TALK ) is a virtual behavioral healthcare company, with a network of around 6,000 licensed professionals that serve all 50 states. It generated $229M in revenue and provided more than 1.6M therapy and psychiatry sessions in 2025. Marc Miller , president and CEO of UHS, said, "This acquisition aligns with UHS' core growth objectives by accelerating our outpatient and telehealth behavioral health strategies, diversifying our payor mix and delivering a comprehensive, technology-enabled continuum of care that supports innovative approaches to mental health services." TALK shares jumped +7.7% premarket at $5.13. More on Talkspace, Universal Health Services Universal Health Services, Inc. (UHS) Presents at TD Cowen 46th Annual Health Care Conference Transcript Universal Health Services, Inc. (UHS) Q4 2025 Earnings Call Transcript Talkspace: Time To Shine As Profitability Takes Off Universal Health Services outlines 2026 revenue target of up to $18.8B while accelerating AI and outpatient expansion Universal Health Services Q4 2025 Earnings Preview
Alexander ( ALX ) on Monday said it has agreed to sell its Rego Park I property to Northwell Health for $235.5M, expecting net proceeds of about $202M. The transaction is expected to generate a financial statement gain of about $147M and a tax gain of roughly $145M, with $48M recognized in 2025 and about $97M in 2026. The sale is expected to close by the third quarter of 2026, subject to customary...
Alexander ( ALX ) on Monday said it has agreed to sell its Rego Park I property to Northwell Health for $235.5M, expecting net proceeds of about $202M. The transaction is expected to generate a financial statement gain of about $147M and a tax gain of roughly $145M, with $48M recognized in 2025 and about $97M in 2026. The sale is expected to close by the third quarter of 2026, subject to customary closing conditions. More on Alexander's Alexander's: Fed Tailwinds Drive FFO Growth Bottom 10 small-cap stocks with the lowest dividend safety grade Top performing retail REITs year to date for 2025 Seeking Alpha’s Quant Rating on Alexander's Historical earnings data for Alexander's
Subadra Rajappa, head of research at Societe Generale Americas, says US Treasuries “are not a good flight to quality hedge in this environment.” (Source: Bloomberg)
Subadra Rajappa, head of research at Societe Generale Americas, says US Treasuries “are not a good flight to quality hedge in this environment.” (Source: Bloomberg)
nito100/iStock Editorial via Getty Images Amazon Pharmacy ( AMZN ) is expanding its offering of weight loss medications on its platform with Eli Lilly’s ( LLY ) Zepbound KwikPen now available for same-day delivery. With a valid prescription, customers can buy Zepbound KwikPen, starting at $299 per month for the 2.5 mg starter dose, and receive the injectable weight loss medication delivered as soo...
nito100/iStock Editorial via Getty Images Amazon Pharmacy ( AMZN ) is expanding its offering of weight loss medications on its platform with Eli Lilly’s ( LLY ) Zepbound KwikPen now available for same-day delivery. With a valid prescription, customers can buy Zepbound KwikPen, starting at $299 per month for the 2.5 mg starter dose, and receive the injectable weight loss medication delivered as soon as the same day in nearly 3,000 locations. In addition to Zepbound, Amazon Pharmacy ( AMZN ) also offers access to FDA-approved GLP-1 medications, including Eli Lilly’s ( LLY ) Wegovy pill, Mounjaro, and Novo Nordisk’s ( NVO ) Ozempic. "By expanding access to the Zepbound KwikPen with upfront self-pay pricing, we’re making it easier for customers to get the treatments their doctors prescribe in a simpler way—delivered directly and reliably to their homes," said Amazon Pharmacy’s vice president and general manager, Tanvi Patel. Amazon ( AMZN ) shares were briefly jolted higher on the news but have surrendered gains in sympathy with broader market weakness. More on Amazon Amazon: Berkshire Hathaway Q4 Trimming And Capital Lease Accounting In Focus Amazon: I Bought The Recent Sell-Off Amazon: Not The Best Bang For Your Buck Amazon takes big steps in India with an evolving financial platform Amazon advances grocery delivery options in the key market of Brazil
nito100/iStock Editorial via Getty Images Amazon Pharmacy ( AMZN ) is expanding its offering of weight loss medications on its platform with Eli Lilly’s ( LLY ) Zepbound KwikPen now available for same-day delivery. With a valid prescription, customers can buy Zepbound KwikPen, starting at $299 per month for the 2.5 mg starter dose, and receive the injectable weight loss medication delivered as soo...
nito100/iStock Editorial via Getty Images Amazon Pharmacy ( AMZN ) is expanding its offering of weight loss medications on its platform with Eli Lilly’s ( LLY ) Zepbound KwikPen now available for same-day delivery. With a valid prescription, customers can buy Zepbound KwikPen, starting at $299 per month for the 2.5 mg starter dose, and receive the injectable weight loss medication delivered as soon as the same day in nearly 3,000 locations. In addition to Zepbound, Amazon Pharmacy ( AMZN ) also offers access to FDA-approved GLP-1 medications, including Eli Lilly’s ( LLY ) Wegovy pill, Mounjaro, and Novo Nordisk’s ( NVO ) Ozempic. "By expanding access to the Zepbound KwikPen with upfront self-pay pricing, we’re making it easier for customers to get the treatments their doctors prescribe in a simpler way—delivered directly and reliably to their homes," said Amazon Pharmacy’s vice president and general manager, Tanvi Patel. Amazon ( AMZN ) shares were briefly jolted higher on the news but have surrendered gains in sympathy with broader market weakness. More on Amazon Amazon: Berkshire Hathaway Q4 Trimming And Capital Lease Accounting In Focus Amazon: I Bought The Recent Sell-Off Amazon: Not The Best Bang For Your Buck Amazon takes big steps in India with an evolving financial platform Amazon advances grocery delivery options in the key market of Brazil